A follow-up of the ShortHER trial suggests tumor-infiltrating lymphocytes (TILs) can help identify patients who may benefit ...
Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback